Processa Pharmaceuticals, Inc. Class of Warrant or Right, Outstanding
Processa Pharmaceuticals, Inc. (PCSA) had Class of Warrant or Right, Outstanding of 303.73 thousand shares as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2021-11-12
- 2021-09-30: Class of Warrant or Right, Outstanding 303.73K shares.
- 2021-06-30: Class of Warrant or Right, Outstanding 310.37K shares.
- 2018-03-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2017-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2021-09-30 | 303.73K shares 10-Q · filed 2021-11-12 |
| 2021-06-30 | 310.37K shares 10-Q · filed 2021-08-12 |
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-21 |
| 2017-12-31 | 0.00 shares 10-Q · filed 2018-05-21 |
| 2016-12-31 | 2.00M shares 10-K · filed 2018-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |